NEISVAC-C susp inj ser pré 0.5 ml

7680006560017 CH-656 J07AH07 08.08.
NEISVAC-C susp inj ser pré 0.5 ml
NEISVAC-C susp inj ser pré 0.5 ml
NEISVAC-C susp inj ser pré 0.5 ml
1 / 3
google

Details

Product number
0065601
CPT
-
Packaging group
1
Unit
Fertigspritze(n)
Composition
polysaccharida neisseriae meningitidis C (Stamm C11, de-O-acetyliert) 10 µg conjugatum cum toxoidum tetani 10-20 µg, aluminium 0.5 mg ut aluminii hydroxidum hydricum ad adsorptionem, natrii chloridum corresp. natrium 1.6 mg, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.

Articles (1)

NeisVac-C, Injektionssuspension
Injektionssuspension
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
20/09/2023
Professional SmPC
Français
20/09/2023
Professional SmPC
Italien
20/09/2023

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIIS
(N/A)
0.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.6 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 45.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2003

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
656
Drug name
NeisVac-C, Injektionssuspension
Galenic form
INJFS
ATC Code
J07AH07
Authorization status
Z
Dispensation category
B
First authorization
04/06/2002
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Meningokokken der Serogruppe C, ab dem vollendeten 2. Lebensmonat

Packaging details

Description (FR)
NEISVAC-C susp inj ser pré 0.5 ml
Description (DE)
NEISVAC-C Inj Susp Fertspr 0.5 ml
Market launch
04/06/2002
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes